Arsonoliposomes: Effect of arsonolipid acyl chain length and vesicle composition on their toxicity towards cancer and normal cells in culture

European Journal of Pharmaceutical Sciences

Volumn 18, Issue 2, 2003, Pages 175-183

  Gortzi, Olga ^a   Antimisiaris, Sophia G ^a   Klepetsanis, Pavlos ^a   Papadimitriou, Evangelia ^a   Ioannou, Panayiotis V ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Arsenic; Arsonolipid; Arsonoliposome; Cell viability; Cytotoxicity; Liposome

Indexed keywords

CELL CULTURE; LIPIDS; TOXICITY; TUMORS;

CYTOTOXIC ACTIVITY;

DRUG PRODUCTS;

ARSONOLIPOSOME; LIPID; LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL COUNT; CELL SURVIVAL; CELL TYPE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPID VESICLE; NONHUMAN; PRIORITY JOURNAL; UMBILICAL VEIN;

EID: 0037312602     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(02)00259-2     Document Type: Article

References (21)

1. Akao Y., Nakagawa Y., Akiyama K. Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. FEBS Lett. 455:1999;59.
2. Bode A.M., Dong Z. The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit. Rev. Oncol./Hematol. 42:2002;5.
3. Carre M., Carles G., Andre N., Douillard S., Ciccolini C., Briand C., Braguer D. Involvement of microtubules and mitochondria in the antagonism of arsenic trioxide on paclitaxel-induced apoptosis. Biochem. Pharmacol. 63:2002;1831.
4. Fatouros D., Gortzi O., Klepetsanis P., Antimisiaris S.G., Stuart M.C.A., Brisson A., Ioannou P.V. Preparation and properties of arsonolipid containing liposomes. Chem. Phys. Lipids. 109:2001;75.
5. Gortzi O., Papadimitriou E., Kontoyannis C., Antimisiaris S.G., Ioannou P.V. Arsonoliposomes, a novel class of arsenic-containing liposomes: effect of palmitoyl-arsonolipid-containing liposomes on the viability of cancer and normal cells in culture. Pharm. Res. 19:2002;79.
6. Gregoriadis G. Liposome Technology. 2nd Edition:1993;CRC Press, Boca Raton, FL.
7. Lasic D.D., Papahadjopoulos D. Liposomes revised. Science. 267:1995;1275.
8. Lasic D.D., Papahadjopoulos D. Medical Applications of Liposomes. 1998;Elsevier Science, Amsterdam.
9. Lu M., Levin J., Sulpice E., Sequeira-Le Grand A., Alemany M., Caen J.P., Han Z.C. Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines. Exp. Hematol. 27:1999;845.
10. Mosmann T.J. Rapid colorimetric assay for cellular growth and survival - application to proliferation and cytotoxicity assays. Immunol. Methods. 65:1983;5.
11. New R.R.C. New R.R.C. Liposomes: A Practical Approach. 1990;134 IRL Press, Oxford University Press, Oxford. see also p. 255.
12. Papadimitriou E., Antimisiaris S.G. Interactions of PC/Chol and PS/Chol liposomes with human cells in vitro. J. Drug Target. 8:2000;335.
13. Roboz G.J., Diaz S., Lam G., Lane W.L., Soignet S.L., Warell R.P., Rafii S. Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood. 96:2000;1525.
14. Serves S.V., Sotiropoulos D.N., Ioannou P.V., Jain M.K. Synthesis of (R)- and (S)-1,2-diacyloxypropyl-3-arsonic acids: optically active arsonolipids. Phosphorus Sulfur Silicon. 71:1992;99.
15. Serves S.V., Sotiropoulos D.N., Ioannou P.V., Jain M.K. One pot synthesis of arsonolipid via thioarsenite precursors. Phosphorus Sulfur Silicon. 81:1993;181.
16. Soignet S.L., Maslak P., Wang Z.G., Jhanwar S., Calleja E., Dardashti L.J., Carso D., De Blasio A., Gabrilove J., Scheinberg D.A., Pandolfi P.P., Warrell R.P. Jr. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. New Engl. J. Med. 339:1998;1341.
17. Stewart J.C.M. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 104:1980;10.
18. Timotheatou D., Ioannou P.V., Scozzafava A., Briganti F., Supuran C.T. Carbonic anhydrase interaction with lipothioarsenites: a novel class of isozymes I and II inhibitors. Metal-Based Drugs. 3:1996;263.
19. Tsivgoulis G.M., Sotiropoulos D.N., Ioannou P.V. 1,2-Dihydroxypropyl-3-arsonic acid: a key intermediate for arsonolipids. Phosphorus Sulfur Silicon. 57:1991;189.
20. Tsivgoulis G.M., Sotiropoulos D.N., Ioannou P.V. rac-1,2-Diacyloxypropyl-3-arsonic acids: arsonolipid analogues of phosphonolipids. Phosphorus Sulfur Silicon. 63:1991;329.
21. Zarif L. Elongated supramolecular assemblies in drug delivery. Rev. J. Controlled Release. 81:2002;7.